Search

Daniel E. Kolker

Supervisory Patent Examiner (ID: 15434, Phone: (571)272-3181 , Office: P/1644 )

Most Active Art Unit
1649
Art Unit(s)
1645, 1644, 1646, 1649
Total Applications
545
Issued Applications
176
Pending Applications
78
Abandoned Applications
291

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19338511 [patent_doc_number] => 12048682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-30 [patent_title] => Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy [patent_app_type] => utility [patent_app_number] => 17/855327 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12324 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855327 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/855327
Combination of micheliolide derivatives or nanoparticles with ionizing radiation and checkpoint inhibitors for cancer therapy Jun 29, 2022 Issued
Array ( [id] => 19026368 [patent_doc_number] => 11925710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-12 [patent_title] => Modified release compositions of a GAMMA-hydroxybutyric acid derivative [patent_app_type] => utility [patent_app_number] => 17/843097 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 44 [patent_no_of_words] => 22815 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843097 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/843097
Modified release compositions of a GAMMA-hydroxybutyric acid derivative Jun 16, 2022 Issued
Array ( [id] => 18107884 [patent_doc_number] => 20230000764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => PRESSURIZED NUTRITIONAL SUPPLEMENT DELIVERY [patent_app_type] => utility [patent_app_number] => 17/839128 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1905 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839128 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/839128
PRESSURIZED NUTRITIONAL SUPPLEMENT DELIVERY Jun 12, 2022 Abandoned
Array ( [id] => 17894702 [patent_doc_number] => 20220304364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => ORAL PRODUCT AND METHOD OF MANUFACTURE [patent_app_type] => utility [patent_app_number] => 17/836661 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836661
ORAL PRODUCT AND METHOD OF MANUFACTURE Jun 8, 2022 Pending
Array ( [id] => 17881024 [patent_doc_number] => 20220296501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => ORAL COMPOSITION WITH POLYMERIC COMPONENT [patent_app_type] => utility [patent_app_number] => 17/834989 [patent_app_country] => US [patent_app_date] => 2022-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17834989 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/834989
ORAL COMPOSITION WITH POLYMERIC COMPONENT Jun 7, 2022 Pending
Array ( [id] => 18167251 [patent_doc_number] => 20230033858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => DIRECT APPLICATION SYSTEM AND METHOD FOR THE DELIVERY OF BIOACTIVE COMPOSITIONS AND FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/832416 [patent_app_country] => US [patent_app_date] => 2022-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64108 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17832416 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/832416
DIRECT APPLICATION SYSTEM AND METHOD FOR THE DELIVERY OF BIOACTIVE COMPOSITIONS AND FORMULATIONS Jun 2, 2022 Abandoned
Array ( [id] => 17881236 [patent_doc_number] => 20220296713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => BIOPHOTONIC COMPOSITIONS FOR TREATING SKIN AND SOFT TISSUE WOUNDS HAVING EITHER OR BOTH NON-RESISTANT AND RESISTANT INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/745058 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745058 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/745058
BIOPHOTONIC COMPOSITIONS FOR TREATING SKIN AND SOFT TISSUE WOUNDS HAVING EITHER OR BOTH NON-RESISTANT AND RESISTANT INFECTIONS May 15, 2022 Abandoned
Array ( [id] => 19279884 [patent_doc_number] => 20240216356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => TASTE MASKED COMPOSTIONS OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND ORALLY DISENTEGRATING TABLET COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 18/557666 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16297 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557666 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/557666
TASTE MASKED COMPOSTIONS OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE, AND ORALLY DISENTEGRATING TABLET COMPRISING THE SAME May 5, 2022 Pending
Array ( [id] => 19496382 [patent_doc_number] => 20240335400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => GASTRIC RESIDENCE SYSTEMS COMPRISING METHADONE [patent_app_type] => utility [patent_app_number] => 18/289326 [patent_app_country] => US [patent_app_date] => 2022-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30151 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289326 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/289326
GASTRIC RESIDENCE SYSTEMS COMPRISING METHADONE May 3, 2022 Pending
Array ( [id] => 18183574 [patent_doc_number] => 20230044304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => Nitric oxide generation, dilution, analysis, and topical application compositions, systems, apparatus and methods [patent_app_type] => utility [patent_app_number] => 17/727651 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35983 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727651 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/727651
Nitric oxide generation, dilution, analysis, and topical application compositions, systems, apparatus and methods Apr 21, 2022 Abandoned
Array ( [id] => 18108245 [patent_doc_number] => 20230001125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => NITRIC OXIDE GENERATION, DILUTION, AND TOPICAL APPLICATION COMPOSITIONS, SYSTEMS, APPARATUS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/727630 [patent_app_country] => US [patent_app_date] => 2022-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6236 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727630 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/727630
NITRIC OXIDE GENERATION, DILUTION, AND TOPICAL APPLICATION COMPOSITIONS, SYSTEMS, APPARATUS AND METHODS Apr 21, 2022 Abandoned
Array ( [id] => 19246655 [patent_doc_number] => 20240197639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => CAPSULE FOR SPECIFIC DRUG DELIVERY AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 18/287244 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8106 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287244 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/287244
CAPSULE FOR SPECIFIC DRUG DELIVERY AND PREPARATION METHOD THEREFOR Apr 19, 2022 Pending
Array ( [id] => 19338519 [patent_doc_number] => 12048690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-30 [patent_title] => Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn [patent_app_type] => utility [patent_app_number] => 17/658849 [patent_app_country] => US [patent_app_date] => 2022-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21928 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17658849 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/658849
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn Apr 11, 2022 Issued
Array ( [id] => 18018870 [patent_doc_number] => 20220370369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => FORMULATION OF INTRINSICALLY ACID-RESISTANT VEGETARIAN-BASED AND GELATIN-BASED SOFT GEL CAPSULES FOR PHARMACEUTICAL/ NUTRACEUTICAL PRODUCTS [patent_app_type] => utility [patent_app_number] => 17/711602 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2607 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711602 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/711602
FORMULATION OF INTRINSICALLY ACID-RESISTANT VEGETARIAN-BASED AND GELATIN-BASED SOFT GEL CAPSULES FOR PHARMACEUTICAL/ NUTRACEUTICAL PRODUCTS Mar 31, 2022 Abandoned
Array ( [id] => 17733178 [patent_doc_number] => 20220218637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => Volatile Organic Compound Formulations Having Antimicrobial Activity [patent_app_type] => utility [patent_app_number] => 17/705993 [patent_app_country] => US [patent_app_date] => 2022-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705993 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/705993
Volatile organic compound formulations having antimicrobial activity Mar 27, 2022 Issued
Array ( [id] => 18027733 [patent_doc_number] => 11510892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Pharmacokinetics of combined release formulations of a g-hydroxybutyric acid derivative [patent_app_type] => utility [patent_app_number] => 17/698609 [patent_app_country] => US [patent_app_date] => 2022-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 31819 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698609 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/698609
Pharmacokinetics of combined release formulations of a g-hydroxybutyric acid derivative Mar 17, 2022 Issued
Array ( [id] => 19155953 [patent_doc_number] => 20240148659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => LIQUID VISCOELASTIC SWALLOWING AID TO PROMOTE SAFE SWALLOWING OF SOLID ORAL DOSAGE FORMS (SODF) [patent_app_type] => utility [patent_app_number] => 18/549652 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549652 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549652
LIQUID VISCOELASTIC SWALLOWING AID TO PROMOTE SAFE SWALLOWING OF SOLID ORAL DOSAGE FORMS (SODF) Mar 10, 2022 Pending
Array ( [id] => 18777819 [patent_doc_number] => 11819494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-21 [patent_title] => Treatment of idiopathic pulmonary fibrosis [patent_app_type] => utility [patent_app_number] => 17/680654 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14126 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680654 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/680654
Treatment of idiopathic pulmonary fibrosis Feb 24, 2022 Issued
Array ( [id] => 17759903 [patent_doc_number] => 20220233515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => Pharmaceutical Composition [patent_app_type] => utility [patent_app_number] => 17/668811 [patent_app_country] => US [patent_app_date] => 2022-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668811 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/668811
Pharmaceutical Composition Feb 9, 2022 Abandoned
Array ( [id] => 19554719 [patent_doc_number] => 20240366511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => ORAL SOLID DOSE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/262938 [patent_app_country] => US [patent_app_date] => 2022-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11645 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262938 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/262938
ORAL SOLID DOSE FORMULATIONS Feb 2, 2022 Pending
Menu